Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Director comp.
MoonLake Immunotherapeutics Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 2.1% stake in MoonLake Immunotherapeutics
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/27/2023 SC 13G/A Merck Healthcare KGaA reports a 7.9% stake in MoonLake Immunotherapeutics
02/14/2022 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 6.2% stake in Helix Acquisition Corp
02/14/2022 SC 13G/A CITADEL ADVISORS LLC reports a 5.8% stake in Helix Acquisition Corp
11/15/2021 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in HELIX ACQUISITION CORP.
02/16/2021 SC 13G/A CITADEL ADVISORS LLC reports a 5.8% stake in Helix Acquisition Corp.
02/11/2021 SC 13G/A ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 8.5% stake in Helix Acquisition Corp.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy